Myriad Genetics
MYGN
$18.63
Share price
0.16%
Change (1 day)
-14.81%
Change (1 year)
Earnings for Myriad Genetics (MYGN)
Earnings in 2023 (TTM): -$0.26 B
According to Myriad Genetics's latest financial reports the company's current earnings (TTM) are -$0.26 B. a decrease over its 2022 earnings that were of -$0.14 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Myriad Genetics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$0.26 B | 88.72% |
| 2022 | -$0.14 B | 172.08% |
| 2021 | -$50.5 M | |
| 2019 | -$26.3 M | -175.14% |
| 2018 | $35 M | -70.81% |
| 2017 | $0.11 B | 22.22% |
| 2016 | $98.1 M | -38.8% |
| 2015 | $0.16 B | -6.12% |
| 2014 | $0.17 B | -41.07% |
| 2013 | $0.28 B | 46.67% |
| 2012 | $0.19 B | 15.84% |
| 2011 | $0.17 B | 17.6% |
| 2010 | $0.14 B | -15.96% |
| 2009 | $0.17 B | |
| 2007 | -$41.68 M | 40.96% |
| 2006 | -$29.57 M | |
| 2003 | -$34.34 M | 34.8% |
| 2002 | -$25.48 M | 89.21% |
| 2001 | -$13.47 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $6.66 B | -2,670.00% | 🇺🇸 USA |
 Exact Sciences EXAS | -$0.18 B | -31.56% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.18 B | -172.72% | 🇺🇸 USA |
 Biocept
BIOC | -$34.97 M | -86.51% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -$0.86 B | 227.85% | 🇺🇸 USA |